NASDAQ:ALRN
Aileron Therapeutics
- Stock
Last Close
1.93
10/01 21:00
Market Cap
66.06M
Beta: 2.01
Volume Today
63.39K
Avg: 53.55K
PE Ratio
−1.68
PFCF: −1.64
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -12.88M - | -18.12M 40.73% | -22.60M 24.73% | -31.55M 39.56% | -29.37M 6.90% | -21.16M 27.96% | -26.16M 23.67% | -27.33M 4.45% | -15.73M 42.43% | |
depreciation and amortization | 325K - | 232K 28.62% | 129K 44.40% | 218K 68.99% | 155K 28.90% | 163K 5.16% | 121K 25.77% | 169K 39.67% | 151K 10.65% | |
deferred income tax | 1.51M - | -152K 110.05% | ||||||||
stock based compensation | 626K - | 688K 9.90% | 1.75M 154.22% | 3.28M 87.54% | 2.12M 35.49% | 1.89M 10.54% | 2.26M 19.39% | 2.08M 7.83% | 1.19M 42.87% | |
change in working capital | 238K - | 695K 192.02% | 358K 48.49% | 376K 5.03% | 850K 126.06% | -1.28M 250.59% | 242K 118.91% | 420K 73.55% | -4.98M 1,286.19% | |
accounts receivables | ||||||||||
inventory | ||||||||||
accounts payables | -237K - | 1.22M 612.66% | -241K 119.84% | 130K 153.94% | -277K 313.08% | 116K 141.88% | -386K 432.76% | 510K 232.12% | -4.98M 1,076.86% | |
other working capital | 475K - | -520K 209.47% | 599K 215.19% | 246K 58.93% | 1.13M 358.13% | -1.40M 223.87% | 628K 144.99% | -90K 114.33% | 4.98M 5,635.56% | |
other non cash items | -21K - | -18K 14.29% | -11K 38.89% | -253K 2,200% | -226K 10.67% | -95K 57.96% | -213K 124.21% | -208K 2.35% | -5.42M 2,504.33% | |
net cash provided by operating activities | -11.71M - | -15.01M 28.22% | -20.53M 36.75% | -27.93M 36.02% | -26.47M 5.20% | -20.48M 22.66% | -23.75M 16.01% | -24.86M 4.68% | -19.81M 20.34% | |
investments in property plant and equipment | -94K - | -142K - | -4.42M 3,014.79% | -151K 96.59% | -5K 96.69% | -157K 3,040% | ||||
acquisitions net | 2.66K - | 208K 7,710.74% | 66K 68.27% | -96K - | ||||||
purchases of investments | -2.37M - | -12.63M 433.53% | -71.06M 462.42% | -31.19M 56.10% | -27.24M 12.69% | -10.03M 63.16% | -73.58M 633.28% | -21.85M 70.30% | ||
sales maturities of investments | 12.38M - | 12.63M 2.07% | 32.29M 155.55% | 60.30M 86.78% | 24.57M 59.25% | 16.24M 33.91% | 37.75M 132.43% | 48.31M 27.97% | 16.25M 66.36% | |
other investing activites | 713K - | -25K 103.51% | -2.66K - | 42K - | ||||||
net cash used for investing activites | 10.63M - | -25K 100.24% | -38.91M 155,548% | 24.69M 163.45% | -2.81M 111.40% | 6.41M 327.83% | -35.92M 660.24% | 26.46M 173.67% | 16.20M 38.79% | |
debt repayment | -387K - | |||||||||
common stock issued | 52.31M - | 23.80M - | 15.41M 35.24% | 55.58M 260.62% | ||||||
common stock repurchased | -91K - | |||||||||
dividends paid | ||||||||||
other financing activites | -1.27M - | 31.99M 2,622.56% | -1.72M 105.38% | 2.52M 246.05% | 165K 93.44% | 774K 369.09% | 74K 90.44% | 15.79M - | ||
net cash used provided by financing activities | -1.36M - | 31.99M 2,453.64% | 50.59M 58.17% | 2.52M 95.03% | 23.96M 852.84% | 15.80M 34.07% | 55.66M 252.26% | 15.79M - | ||
effect of forex changes on cash | -63K - | |||||||||
net change in cash | -2.44M - | 16.95M 794.55% | -8.85M 152.23% | -723K 91.83% | -5.32M 636.38% | 1.74M 132.59% | -4.01M 331.35% | 1.59M 139.71% | 12.12M 660.29% | |
cash at beginning of period | 6.21M - | 3.77M 39.30% | 20.71M 449.76% | 11.95M 42.31% | 11.23M 6.05% | 5.90M 47.42% | 7.64M 29.39% | 3.63M 52.55% | 5.22M 43.97% | |
cash at end of period | 3.77M - | 20.71M 449.76% | 11.86M 42.73% | 11.23M 5.35% | 5.90M 47.42% | 7.64M 29.39% | 3.63M 52.55% | 5.22M 43.97% | 17.34M 232.21% | |
operating cash flow | -11.71M - | -15.01M 28.22% | -20.53M 36.75% | -27.93M 36.02% | -26.47M 5.20% | -20.48M 22.66% | -23.75M 16.01% | -24.86M 4.68% | -19.81M 20.34% | |
capital expenditure | -94K - | -142K - | -4.42M 3,014.79% | -151K 96.59% | -5K 96.69% | -157K 3,040% | ||||
free cash flow | -11.80M - | -15.01M 27.19% | -20.67M 37.69% | -32.35M 56.48% | -26.63M 17.69% | -20.48M 23.08% | -23.91M 16.75% | -24.86M 3.99% | -19.81M 20.34% |
All numbers in USD (except ratios and percentages)